StockData
International Stem Cell CORP logo

International Stem Cell CORP (ISCO) stock

ISCOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
$0.28+0.00 (+0.89%)

Close on Oct 19, 2026Market cap $2.27MP/E –Yield –

International Stem Cell free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

International Stem Cell's free cash flow for the twelve months ending Jun 30, 2026 was $333.00K, up 851.4% year over year. For fiscal 2025 it was -$35.00K. The highest annual figure on record is $849.00K in fiscal 2023.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$35.00K–
FY2024Dec 31, 2024-$153.00K-118.0%
FY2023Dec 31, 2023$849.00K+156.5%
FY2022Dec 31, 2022$331.00K–
FY2021Dec 31, 2021-$1.32M–
FY2020Dec 31, 2020-$369.00K–
FY2019Dec 31, 2019-$1.56M–
FY2018Dec 31, 2018-$1.27M–
FY2017Dec 31, 2017-$2.25M–
FY2016Dec 31, 2016-$4.43M–
FY2015Dec 31, 2015-$4.16M–
FY2014Dec 31, 2014-$6.71M–
FY2013Dec 31, 2013-$5.81M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$160.00K–
Q1 FY2026Mar 31, 2026$98.00K-55.9%
Q4 FY2025Dec 31, 2025$29.00K–
Q3 FY2025Sep 30, 2025$46.00K-79.1%
Q2 FY2025Jun 30, 2025-$332.00K–
Q1 FY2025Mar 31, 2025$222.00K–
Q4 FY2024Dec 31, 2024-$75.00K-146.6%
Q3 FY2024Sep 30, 2024$220.00K+358.3%
Q2 FY2024Jun 30, 2024-$97.00K-122.1%
Q1 FY2024Mar 31, 2024-$201.00K-200.0%
Q4 FY2023Dec 31, 2023$161.00K+103.8%
Q3 FY2023Sep 30, 2023$48.00K-42.9%
Q2 FY2023Jun 30, 2023$439.00K–
Q1 FY2023Mar 31, 2023$201.00K–
Q4 FY2022Dec 31, 2022$79.00K–
Q3 FY2022Sep 30, 2022$84.00K-67.9%
Q4 FY2020Dec 31, 2020-$315.00K–
Q3 FY2020Sep 30, 2020-$279.00K–
Q2 FY2020Jun 30, 2020-$37.00K–
Q1 FY2020Mar 31, 2020$262.00K–
Q4 FY2019Dec 31, 2019-$399.00K-6750.0%
Q3 FY2019Sep 30, 2019-$60.00K–
Q2 FY2019Jun 30, 2019-$703.00K–
Q1 FY2019Mar 31, 2019-$399.00K–
Q4 FY2018Dec 31, 2018$6.00K–
Q3 FY2018Sep 30, 2018-$566.00K–
Q2 FY2018Jun 30, 2018-$602.00K–
Q1 FY2018Mar 31, 2018-$105.00K–
Q4 FY2017Dec 31, 2017-$516.00K–
Q3 FY2017Sep 30, 2017-$348.00K–
Q2 FY2017Jun 30, 2017-$811.00K–
Q1 FY2017Mar 31, 2017-$579.00K–
Q4 FY2016Dec 31, 2016-$976.00K–
Q3 FY2016Sep 30, 2016-$457.00K–
Q2 FY2016Jun 30, 2016-$965.00K–

More International Stem Cell figures

See a number that looks wrong?